CARLSBAD, Calif., Nov. 10,
2022 /PRNewswire/ -- Ionis Pharmaceuticals, Inc.
(Nasdaq: IONS) today announced that management will participate in
fireside chats at the following investor conferences:
- Guggenheim 4th Annual Immunology and Neurology Day
on Monday, November 14, 2022
- Stifel 2022 Healthcare Conference on Tuesday, November 15, 2022
- 5th Annual Evercore ISI HealthCONx on Tuesday, November 29, 2022
- Piper Sandler 34th
Annual Healthcare Conference on Tuesday,
November 29, 2022
- Nasdaq 47th Investor Conference on Wednesday, December 7, 2022
- BMO 2022 Growth & ESG Conference on Wednesday, December 7, 2022
A live webcast and additional information about each
presentation can be accessed on the Investors & Media section
of the Ionis website at www.ionispharma.com. Replays will be
available on the Ionis website within 48 hours of each event.
About Ionis Pharmaceuticals
For more than 30 years,
Ionis has been the leader in RNA-targeted therapy, pioneering new
markets and changing standards of care with its novel antisense
technology. Ionis currently has three marketed medicines and a
premier late-stage pipeline highlighted by industry-leading
cardiovascular and neurological franchises. Our scientific
innovation began and continues with the knowledge that sick people
depend on us, which fuels our vision of becoming a leading, fully
integrated biotechnology company.
To learn more about Ionis, visit www.ionispharma.com and follow
us on Twitter @ionispharma
View original content to download
SOURCE Ionis Pharmaceuticals, Inc.